Pharmacopeia

Canonical comparison

Master Compare

Compare candidate-facing canonical Pharmacopeia fields side by side. Isolated AI-draft proposals are never included.

2selected
Comparing 2 of 2 drugs
× ×
Change selection
2 drug columns · use arrows or scrollbar
Field FRUSEMIDE
Renal · Renal · Level 1
HYDROCHLOROTHIAZIDE
Renal · Renal · Level 3
Mechanism of action

Diuresis
Inhibition of active chloride ion reabsorption in PCT and ascending limb of LoH
↓ reabsorption of NaCl → ↓ tonicity in the renal medulla → ↓water reabsorption and diuresis.
Other effects are mediated by the induction of the COX-2 enzyme which assists in synthesis of prostaglandins.

inhibit Na+ reabsorption in the early portion of the distal tubule by
blocking the Na+.Cl- symporter in the apical membrane of these cells. Naturesis
occurs with thiazide diuretics is 5-10% of the filtered load

Physiological effects

Pulmonary and systemic vasodilation
Diuresis ↑ RBF and ↑ corticomedullary blood flow
↓O₂ demand in the LoH (ischaemic
protection)

Anti-HTN: (↓TPR, ↓plasma volume)
↓RBF → ↓GFR
↓K+,Na+,Mg.
Hyperchloremic MA
↑Ca++ (↓excretion)
↑Glu: (↓glycogenolysis, ↓insulin)

Absorption

PO/IV/SL/IM. PO BA 50% Onset PO/SL 30-60mins, IV 5 mins .
Dur PO/SL 6-8hrs, IV 2hrs

PO- BA ~50-80%. Onset 2hrs Dur 6-12hrs.

Protein binding

91-99% (Albumin)

68%

Volume of distribution

0.1L/kg

3.6-7.8L/kg

Metabolism

Renal to glucuronide
Minimal hepatic

Not metabolized

Excretion

80% unchanged in urine

Urine (unchanged)

Half-life

0.5-2hrs. ESRF: 9hrs

5.6-14.8hrs

Adverse Effects Toxicity

↓ K+/Na+/Cl-/Ca++, Hyper- urea/glu/chol, Metabolic alkalosis
Tox: Deafness, Pancreatitis
BM depression
Interstitial nephritis (worse with aminoglycoside)

↓K+/Na+/Mg++, ↑Ca++/urea/glu/chol.
indiosyncratic blood
dyscrasias. Rash, photsensitivity. Interactions may prolong action of NDMBs. NSAIDs antagonise the action

Class Group

Diuretic - Loop

Diuretic - Thiazide

Indications Uses

Oedema of cardiac, renal or hepatic origin, Renal insufficency
Hypertension
Raised ICP
Hypercalcaemia

heart failure and hypertension. Used in combination. mostly bound to plasma prot, and gain access to the tubule via secretion in the PCT.

Introduction

Sulfonamide derivative

related to the sulphonamides

Legacy Cicm Level

Level 1

Level 3

Presentation

Photosensitive solution 10mg/ml
20/40/500mg tabs, Syrup

orange scored tablets of 25mg and combos

Route And Dose

20-2000mg daily
PO/IV/SL/IM.

PO. 12.5-200mg/day